458 related articles for article (PubMed ID: 19477292)
1. Major advances in the development of histamine H4 receptor ligands.
Smits RA; Leurs R; de Esch IJ
Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
[TBL] [Abstract][Full Text] [Related]
2. Histamine H4 receptor ligands and their potential therapeutic applications.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2009 Feb; 19(2):119-35. PubMed ID: 19441913
[TBL] [Abstract][Full Text] [Related]
3. Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.
Savall BM; Edwards JP; Venable JD; Buzard DJ; Thurmond R; Hack M; McGovern P
Bioorg Med Chem Lett; 2010 Jun; 20(11):3367-71. PubMed ID: 20452213
[TBL] [Abstract][Full Text] [Related]
4. Histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keserű GM
Expert Opin Ther Pat; 2012 Mar; 22(3):205-21. PubMed ID: 22385042
[TBL] [Abstract][Full Text] [Related]
5. Novel histamine H4 receptor ligands and their potential therapeutic applications: an update.
Kiss R; Keseru GM
Expert Opin Ther Pat; 2014 Nov; 24(11):1185-97. PubMed ID: 25219452
[TBL] [Abstract][Full Text] [Related]
6. Histamine H3 and H4 receptors as novel drug targets.
Tiligada E; Zampeli E; Sander K; Stark H
Expert Opin Investig Drugs; 2009 Oct; 18(10):1519-31. PubMed ID: 19758107
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements for inverse agonism and neutral antagonism of indole-, benzimidazole-, and thienopyrrole-derived histamine H4 receptor ligands.
Schneider EH; Strasser A; Thurmond RL; Seifert R
J Pharmacol Exp Ther; 2010 Aug; 334(2):513-21. PubMed ID: 20484153
[TBL] [Abstract][Full Text] [Related]
8. Piperazine modification in 2,4,6-triaminopyrimidine derivatives as histamine H4 receptor ligands.
Schreeb A; Walter M; Odadzic D; Schwed JS; Weizel L; Stark H
Pharmazie; 2013 Jul; 68(7):521-5. PubMed ID: 23923631
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and functional characterization of imbutamine analogs as histamine H3 and H4 receptor ligands.
Geyer R; Kaske M; Baumeister P; Buschauer A
Arch Pharm (Weinheim); 2014 Feb; 347(2):77-88. PubMed ID: 24493592
[TBL] [Abstract][Full Text] [Related]
10. Interactions of histamine H1-receptor agonists and antagonists with the human histamine H4-receptor.
Deml KF; Beermann S; Neumann D; Strasser A; Seifert R
Mol Pharmacol; 2009 Nov; 76(5):1019-30. PubMed ID: 19720730
[TBL] [Abstract][Full Text] [Related]
11. En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family.
Leurs R; Vischer HF; Wijtmans M; de Esch IJ
Trends Pharmacol Sci; 2011 Apr; 32(4):250-7. PubMed ID: 21414671
[TBL] [Abstract][Full Text] [Related]
12. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
Altenbach RJ; Adair RM; Bettencourt BM; Black LA; Fix-Stenzel SR; Gopalakrishnan SM; Hsieh GC; Liu H; Marsh KC; McPherson MJ; Milicic I; Miller TR; Vortherms TA; Warrior U; Wetter JM; Wishart N; Witte DG; Honore P; Esbenshade TA; Hancock AA; Brioni JD; Cowart MD
J Med Chem; 2008 Oct; 51(20):6571-80. PubMed ID: 18811133
[TBL] [Abstract][Full Text] [Related]
14. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
15. Compared pharmacology of human histamine H3 and H4 receptors: structure-activity relationships of histamine derivatives.
Gbahou F; Vincent L; Humbert-Claude M; Tardivel-Lacombe J; Chabret C; Arrang JM
Br J Pharmacol; 2006 Apr; 147(7):744-54. PubMed ID: 16432504
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening.
Kiss R; Kiss B; Könczöl A; Szalai F; Jelinek I; László V; Noszál B; Falus A; Keseru GM
J Med Chem; 2008 Jun; 51(11):3145-53. PubMed ID: 18459760
[TBL] [Abstract][Full Text] [Related]
17. Molecular pharmacology of histamine H4 receptors.
Nijmeijer S; de Graaf C; Leurs R; Vischer HF
Front Biosci (Landmark Ed); 2012 Jun; 17(6):2089-106. PubMed ID: 22652766
[TBL] [Abstract][Full Text] [Related]
18. The effect of pK(a) on pyrimidine/pyridine-derived histamine H4 ligands.
Savall BM; Meduna SP; Venable J; Wei J; Smith RC; Hack MD; Thurmond RL; McGovern P; Edwards JP
Bioorg Med Chem Lett; 2014 Dec; 24(23):5489-92. PubMed ID: 25455490
[TBL] [Abstract][Full Text] [Related]
19. Histamine H4 receptor antagonists: the new antihistamines?
Fung-Leung WP; Thurmond RL; Ling P; Karlsson L
Curr Opin Investig Drugs; 2004 Nov; 5(11):1174-83. PubMed ID: 15573868
[TBL] [Abstract][Full Text] [Related]
20. Azines as histamine H4 receptor antagonists.
Lazewska D; Kiec-Kononowicz K
Front Biosci (Schol Ed); 2012 Jan; 4(3):967-87. PubMed ID: 22202103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]